Macalma, Monera .

HRN: 27-33-22  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2025
CEFUROXIME 750MG (VIAL)
12/21/2025
12/27/2025
IV
750mg
Q8
Breast Carcinoma
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines